Registry Trial and Needs Assessment of Patients With Young-onset Lung Cancer: Impact of a Dedicated Care Program on Patient Experience and Outcomes

NCT07220096 | Recruiting

• 2 other identifiers: 2025-0646NCI-2025-07304
• Study Type: observational
• Target: 75
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this research study is to learn about: The effect of enrolling in the YOLC program on patient satisfaction with care provided, The needs of patients younger than 50 with lung cancer and their family, and The impact of participating in peer support networks on these patients.

Conditions

Lung Cancer

Outcome Measures

Primary Outcomes (1)

• Participant satisfaction with care

  Assessed via validated survey instruments (e.g., FACT-L, COST-FACIT). • Focus on detecting even small changes in survey responses over time (baseline, 3, 6, 9, 12 months, etc.).

  Through study completion; an average of 5 year

Study Arms (1)

Assessment of Patients with Young-Onset Lung Cancer

This is a registry trial enrolling participants with NSCLC diagnosed and histologically confirmed prior to the age of 50 years identified. Each participant will participate in an intake survey as well as periodic recurring surveys to provide feedback to the YOLC Program, to elucidate the individual participant's care needs, and to assess changes in personal goals, wellness, financial impact, and family support over time

Other: Survey

Interventions

Survey OTHER

Participants will complete an intake survey and repeat surveys at the following time points: * Baseline * 3 months * 6 months * 9 months * 12 months * 18 months * 24 months * 36 months * 48 months * 60 months

Assessment of Patients with Young-Onset Lung Cancer

Eligibility Criteria

• Age: 18 Years - 50 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

MD Anderson

You may qualify if:

• Age greater than 18 years and under 50 years
• Histologic confirmation of NSCLC
• Able to complete an English-language survey independently or with the assistance of a native-language interpreter
• Pregnant women- may be enrolled due to age range of subjects. (Low risk)

You may not qualify if:

• Medical, psychiatric, cognitive, or other conditions that compromise the patient's ability to understand the patient information, to give informed consent, to comply with the study protocol or to complete the study.
• The following special patient population will be excluded from study group:
• Individuals who are not yet adults (infants, children, teenagers)
• Prisoners
• Cognitively-impaired adults

Sponsors & Collaborators

• M.D. Anderson Cancer Center: lead

Study Sites (1)

The University of Texas M. D. Anderson Cancer Center

Houston, Texas, 77030, United States

RECRUITING

Related Links

• MD Anderson Cancer Center Website

MeSH Terms

Conditions

Lung Neoplasms

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms by Site; Neoplasms; Lung Diseases; Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Eric Singhi, MD

  M.D. Anderson Cancer Center

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Eric Singhi, MD

CONTACT

713-745-2263; eksinghi@mdanderson.org

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 30, 2025
• First Posted: October 23, 2025
• Study Start: September 25, 2025
• Primary Completion (Estimated): May 31, 2029
• Study Completion (Estimated): May 31, 2031
• Last Updated: April 16, 2026

Record last verified: 2026-04

Locations

US (1)